Developing a Robust CQA Monitoring Method via Multi-Attribute Monitoring Principles for Therapeutic Monoclonal Antibody Development, Manufacturing, and Lifecycle Management

Register free: http://www.biopharminternational.com/bp_w/bioaccord

Event Overview:
Quality-by-design (QbD) principles outlined by FDA require a deep understanding of the biopharmaceutical product and process to ensure the desired product quality is met at the end of theOriginal Article